The IMPRS-IDI is a vibrant international doctoral program. We offer outstanding training and support in an excellent scientific network. Our faculty members are affiliated with internationally renowned research institutes in Berlin as well as the Berlin universities. Our mission is to support students to develop into creative and critical, responsible and self-confident young researchers. We strive to provide excellent training to our students. The outstanding research projects analyzing the genetic, biochemical and organismal basis of infections and immune reactions in our graduate school program are supported by a flexible curriculum structure, including training courses and lectures on scientific topics as well as technical and complementary skills.
The International Max Planck Research School for Infectious Diseases and Immunology (IMPRS-IDI) invites applications for up to 5 fully funded PhD positions starting in 2027.
We welcome highly motivated candidates to join our international and interdisciplinary research community and pursue exciting research projects in infection biology and immunology. Successful applicants will conduct their doctoral research at leading Berlin research institutions, including the Max Planck Institute for Infection Biology, German Rheumatology Research Center (DRFZ) and Charité-Universitätsmedizin Berlin.
The following 5 PhD projects are available in 2027:
The IMPRS-IDI is an established international doctoral program with approximately 65 doctoral researchers from more than 25 different countries. Our mission is to support doctoral researchers in becoming creative, critical, responsible and self-confident scientists.
We are looking for:
We offer:
Interested in joining us?
Submit your application through our online application platform by 18 December 2026, 23:59 CET.
Shortlisted candidates will be invited to online panel interviews in March, followed by individual interviews in Berlin. Successful candidates are expected to start their doctoral research between May and December 2027.
For more information on available projects, eligibility criteria and the application process, please visit the IMPRS-IDI website.
ID: 208745